Recent findings from Han et al. and Zhong et al. have demonstrated that change in the expression of PHB1 was linked to human pancreatic carcinoma and that PHB could be used as an early biomarker or a treatment target for pancreatic carcinoma. The gene discussed is PHB1; the disease is exocrine pancreatic carcinoma.